GM-CSF R alpha

GM-CSF R alpha

GM-CSF R alpha Overview

Molecule Name
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha
Synonyms
GM-CSF R alpha,GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CSF2RA,CSF2R,CSF2RY,CDw116,CD116
Drug Development Progress
Drugs in Clinical Trials4
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CD116,Colony Stimulating Factor 2 Receptor Subunit Alpha,Colony Stimulating Factor 2 Receptor, Alpha, Low-Affinity (Granulocyte-Macrophage),CSF2R,CSF2RAX,CSF2RAY,CSF2RX,CSF2RY,GM-CSF Receptor Alpha Subunit,GMCSFR,GMR,Granulocyte-Macrophage Colony-Stimulating Factor Receptor Alpha Chain,SMDP4,Colony Stimulating Factor 2 Receptor Alpha Subunit,CDw116,CD116 Antigen,Alpha-GM-CSF Receptor,AlphaGMR
Background
GM-CSF R alpha(Granulocyte-macrophage colony-stimulating factor receptor subunit alpha) is also known as CSF2RA, CD116, GMR-alpha. Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells. Hereditary pulmonary alveolar proteinosis (hPAP) is a rare disorder of pulmonary surfactant accumulation and hypoxemic respiratory failure caused by mutations in CSF2RA (encoding the granulocyte/macrophage colony-stimulating factor [GM-CSF] receptor α-chain [CD116]), which results in reduced GM-CSF-dependent pulmonary surfactant clearance by alveolar macrophages.

GM-CSF R alpha Product List

Species
  • Human(2)
  • Mouse(1)
Tag
  • His Tag(2)
  • Fc Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(3)
Grade
  • RUO(3)
Low Endotoxin
  • No(3)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
GM-CSF R alpha
Human GM-CSF R alpha Protein, His Tag (SPR verified)
Human
HEK293
SDS-PAGE
ELISASPRBLI

$340.00

100ug
GM-CSF R alpha
Mouse GM-CSF R alpha Protein, His Tag
Mouse
HEK293
SDS-PAGE
ELISA

$360.00

100ug
GM-CSF R alpha
Human GM-CSF R alpha Protein, Fc Tag
Human
HEK293
SDS-PAGE
ELISABLI

$340.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
MavrilimumabCAM-3001; KPL-301; GM-CSFR; CAM3001Phase 3 ClinicalCsl Ltd
Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Giant Cell Arteritis; Pneumonia
Details
Anti-GMR CAR T-cell TherapyPhase 2 ClinicalKyoto Prefectural University Of Medicine, Shinshu University School of Medicine
Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile
Details
CSF2RA gene-corrected macrophages(University of South Florida)Phase 2 ClinicalRussian Academy Of Medical Sciences
Pulmonary Alveolar Proteinosis
Details
STSA-1005STSA-1005; STSA1005Phase 1 ClinicalStaidson(Beijing) Biopharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
Customer Reviews